STUART KLEIN: Open Payments
NPI 1104834472 · POWAY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$983 in 47 payments from 20 companies in 2025. Trend: 2023 $1,074 · 2024 $1,352 · 2025 $983
Food & beverage: $983
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 8 | $183 |
| ABBVIE INC. | 7 | $131 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $107 |
| Lilly USA, LLC | 4 | $85 |
| Indivior Inc. | 2 | $54 |
| Seqirus USA Inc | 2 | $43 |
| AstraZeneca Pharmaceuticals LP | 2 | $42 |
| PFIZER INC. | 2 | $42 |
| Dexcom, Inc. | 2 | $39 |
| Novo Nordisk Inc | 2 | $35 |
Products named: TRELEGY ELLIPTA, XIFAXAN, VRAYLAR, SHINGRIX, SUBLOCADE, JARDIANCE, Flucelvax, AIRSUPRA.
Industry payments across CA — which companies pay providers there.
